1/1
Supplementary Figures – Adjuvant EGFR tyrosine kinase inhibitors forpatients with resectedEGFR-mutatednon-small-cell lung cancer: a networkmeta-analysis
figure
posted on 2022-06-13, 13:25 authored by Figshare Future Science GroupFigshare Future Science Group, Wentao Tian, Nuopei Tan, Jiawen Ke, Ji’an Zou, Xiaohan Liu, Yue Pan, Yue Zeng, Yurong Peng, Fang WuFigure 1: Risk classification
Figure 2: Brooks–Gelmandiagnoses of astringency
Figure 3: Heterogeneity results of head-to-head comparisons in forest plots according to feasible pairwise, back-calculatedand network
Figure 4: Sensitivity analysis
